Pemetrexed in combination with cisplatin or carboplatin as adjuvant chemotherapy in early-stage NSCLC

被引：0
|
作者：
Schmid-Bindert, G.
Chemaissani, A.
Fischer, J. R.
Schuette, W.
Mazieres, J.
Vinolas, N.
Wolf, M.
Vaury, A. Thareau
Leschinger, M.
Reck, M.
机构：
[1] Univ Heidelberg, Univ Ctr Mannheim, D-6800 Mannheim, Germany
[2] Lung Clin Cologne Merheim, Cologne, Germany
[3] Klinikum Loewenstein gGmbH, Loewenstein, Germany
[4] Hosp Martha Maria, Halle Doelau, Germany
[5] Larrey Hosp, Toulouse, France
[6] Hosp Clin Barcelona, Barcelona, Spain
[7] Klinikum Kassel Med Kilin IV, Kassel, Germany
[8] Lilly France, Suresnes, France
[9] Lilly Deutschland GmbH, Bad Homburg, Germany
[10] Hosp Grosshansdorf, Grosshansdorf, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7565
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Pemetrexed in combination with cisplatin or carboplatin as adjuvant chemotherapy in early stage NSCLC
    Manegold, Christian
    Chemaissani, Assaad
    Fischer, Juergen R.
    Schuette, Wolfgang
    Mazieres, Julien
    Vinolas, Nuria
    Wolf, Martin
    Thareau-Vaury, Alexandra
    Leschinger, Monika
    Reck, Martin
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S582 - S583
  • [2] Randomized phase 2 trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed versus cisplatin and vinorelbine: the TREAT study
    Kreuter, M.
    Vansteenkiste, J.
    Fischer, J. R.
    Eberhardt, W.
    Zabeck, H.
    Kollmeier, J.
    Serke, M.
    Frickhofen, N.
    Reck, M.
    Engel-Riedel, W.
    Neumann, S.
    Thomeer, M.
    Schumann, C.
    De Leyn, P.
    Graeter, T.
    Stamatis, G.
    Zuna, I.
    Griesinger, F.
    Thomas, M.
    ANNALS OF ONCOLOGY, 2013, 24 (04) : 986 - 992
  • [3] Cisplatin vs carboplatin in adjuvant NSCLC chemotherapy
    Haridass, A.
    Eswar, C. V.
    Wong, H.
    LUNG CANCER, 2015, 87 : S25 - S26
  • [4] Randomized phase II trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed (CPx) versus cisplatin and vinorelbine (CVb): TREAT.
    Kreuter, M.
    Vansteenkiste, J. F.
    Fischer, J. R.
    Eberhardt, W. E. E.
    Zabeck, H.
    Kollmeier, J.
    Serke, M. H.
    Frickhofen, N.
    Reck, M.
    Engel-Riedel, W.
    Neumann, S.
    Thomeer, M.
    Schumann, C.
    Deleyn, P.
    Graeter, T.
    Stamatis, G.
    Zuna, I.
    Griesinger, F.
    Thomas, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [5] Chemotherapy and Immunotherapy in Early-Stage NSCLC: Neoadjuvant vs Adjuvant Therapy
    Wakelee, Heather
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2023, 21 (12) : 648 - 651
  • [6] Three-Year Follow-Up of a Randomized Phase II Trial on Refinement of Early-Stage NSCLC Adjuvant Chemotherapy with Cisplatin and Pemetrexed versus Cisplatin and Vinorelbine (the TREAT Study)
    Kreuter, Michael
    Vansteenkiste, Johan
    Fischer, Juergen R.
    Eberhardt, Wilfried E.
    Zabeck, Heike
    Kollmeier, Jens
    Serke, Monika
    Frickhofen, Norbert
    Reck, Martin
    Engel-Riedel, Walburga
    Neumann, Silke
    Thomeer, Michiel
    Schumann, Christian
    De Leyn, Paul
    Graeter, Thomas
    Stamatis, Georgios
    Griesinger, Frank
    Thomas, Michael
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (01) : 85 - 93
  • [7] Carboplatin-Pemetrexed as adjuvant chemotherapy in resectable NSCLC: A phase II study
    Charpidou, Andriani G.
    Boura, Paraskevi
    Karapanagiotou, Eleni
    Sepsas, Evangelos
    Papamichalis, George
    Konstantinou, Marios
    Syrigos, Kostas N.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S783 - S783
  • [8] Early-stage NSCLC: promising (neo)adjuvant approaches
    不详
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2019, 12 : E46 - E49
  • [9] Adjuvant chemotherapy for early-stage cervical cancer
    Asano, Hiroshi
    Todo, Yukiharu
    Watari, Hidemichi
    CHINESE JOURNAL OF CANCER RESEARCH, 2016, 28 (02) : 228 - 234
  • [10] Adjuvant chemotherapy for early-stage breast cancer
    McArthur, Heather L.
    Hudis, Clifford A.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2007, 21 (02) : 207 - +
12345